EMEA-001366-PIP01-12-M02

Key facts

Invented name
Sialanar
Active substance
Glycopyrronium (bromide)
Therapeutic area
Neurology
Decision number
P/0240/2014
PIP number
EMEA-001366-PIP01-12-M02
Pharmaceutical form(s)
Oral liquid
Condition(s) / indication(s)
Treatment of sialorrhoea
Route(s) of administration
Oral use
Contact for public enquiries
Proveca Limited
United Kingdom
E-mail: simon@proveca.co.uk 
Tel. +44 (0)7913 048665
Fax +44 (0)1925 321212
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-001366-PIP01-12-M02
Compliance opinion date
14/11/2014
Compliance outcome
positive

Decision

How useful was this page?

Add your rating